LILRB2 and hepatocellular carcinoma: In fact, the LILRB family was found to have increased expression in peripheral blood and in tissue from patients with HCC compared to healthy donors [35]; an overexpression of LILRB2 in particular was positively and significantly correlated with poor prognostic features in HCC patients, including poor cell differentiation, larger primary tumor size, and shorter overall survival [36].